Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Starling Surgical logo — The only wound closure device, as fast as a skin stapler, wi...

Starling Surgical

The only wound closure device, as fast as a skin stapler, with all the clinical advantages of meticulous sutures.

Founded 2017 Ireland Ireland 1 employees Seed Health Care

General Information

Company Name Starling Surgical
Founded Year 2017
Location Ireland Ireland
Employees 1
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Starling Surgical. To contact Starling Surgical, visit starlingsurgical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Starling Surgical compare?

A PDF of Starling Surgical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Starling Surgical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Starling Surgical

Starling Surgical, founded in 2017 and headquartered in Ireland, is a health care startup aiming to revolutionize wound closure technology. Their flagship product, the Quickstitch, boasts being the only wound closure device that offers the clinical benefits of sutures while operating at the speed of a skin stapler. This innovation has attracted the attention of MedTech Innovator, who led the Seed Round investment in the company on 17 June 2019. The company's slogan encapsulates their mission to provide optimal wound closure every time, promising patients a finer scar post-operation. Starling Surgical's commitment is evidenced by their continuous development, testing, and iterations to ensure the Quickstitch delivers exceptional results. Their focus on user experience is highlighted by the device's intuitiveness and simplicity, earning accolades from users. In the competitive health care industry, Starling Surgical's dedication to enhancing patient outcomes through innovative technology positions them as a promising investment opportunity. The recent backing from MedTech Innovator underscores their potential to disrupt the wound closure market and signifies confidence in the Quickstitch's capabilities.

Business keywords: wound closure device, surgical technology, medical innovation, clinical advantages, wound closure, sutures, surgical equipment, patient outcomes, medical devices industry, startup, innovation, surgical procedures, medical devices innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
MedTech Innovator
MedTech Innovator
17 Jun 2019

Starling Surgical Alternatives & Competitors

View All Alternatives
Starling Surgical vs
microMend®
microMend® United States

Designed to replace sutures and staples, microMend PRO devices are the ideal solution for healthcare...

Series B
11 employees
Biotechnology, Health Care
Starling Surgical vs
TissueLink Medical
TissueLink Medical

Pioneering global medical technology since 1999, delivering advanced energy devices for versatile su...

Venture round
14 employees
Biotechnology, Health Care
Starling Surgical vs
Angiotech Pharmaceuticals
Angiotech Pharmaceuticals

Enhancing the future of healthcare with innovative medical solutions and technologies for local dise...

Private Equity
1001-5000 employees
Health Care, Medical Devices
Also compare with: Starling Surgical vs GI Windows Surgical GI Windows Surgical View all alternatives

FAQ About Starling Surgical

The only wound closure device, as fast as a skin stapler, with all the clinical advantages of meticulous sutures.
Starling Surgical was founded in 2017.
Starling Surgical is headquartered in Ireland.
Starling Surgical operates in Health Care. Its work centres on wound closure device, surgical technology, medical innovation and clinical advantages.
Starling Surgical has approximately 1 employees.
Starling Surgical has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Starling Surgical include microMend®, TissueLink Medical, Angiotech Pharmaceuticals, InventoRR MD, AsparaGlue. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Starling Surgical and microMend® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Starling Surgical, https://bouncewatch.com/company/starling-surgical, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout